Time series analysis of comprehensive maternal deaths in Brazil during the COVID-19 pandemic.

Time series analysis of comprehensive maternal deaths in Brazil during the COVID-19 pandemic.

Publication date: Oct 14, 2024

The effects of the COVID-19 pandemic on comprehensive maternal deaths in Brazil have not been fully explored. Using publicly available data from the Brazilian Mortality Information (SIM) and Information System on Live Births (SINASC) databases, we used two complementary forecasting models to predict estimates of maternal mortality ratios using maternal deaths (MMR) and comprehensive maternal deaths (MMRc) in the years 2020 and 2021 based on data from 2008 to 2019. We calculated national and regional standardized mortality ratio estimates for maternal deaths (SMR) and comprehensive maternal deaths (SMRc) for 2020 and 2021. The observed MMRc in 2021 was more than double the predicted MMRc based on the Holt-Winters and autoregressive integrated moving average models (127. 12 versus 60. 89 and 59. 12 per 100,000 live births, respectively). We found persisting sub-national variation in comprehensive maternal mortality: SMRc ranged from 1. 74 (95% confidence interval [CI] 1. 64, 1. 86) in the Northeast to 2. 70 (95% CI 2. 45, 2. 96) in the South in 2021. The observed national estimates for comprehensive maternal deaths in 2021 were the highest in Brazil in the past three decades. Increased resources for prenatal care, maternal health, and postpartum care may be needed to reverse the national trend in comprehensive maternal deaths.

Open Access PDF

Concepts Keywords
Brazil Adult
Databases Brazil
Decades Brazil
Pandemic Comprehensive maternal deaths
Prenatal COVID-19
COVID-19
Databases, Factual
Female
Humans
Maternal Death
Maternal Mortality
Maternal mortality
Pandemics
Pregnancy
SARS-CoV-2
Time series analysis

Semantics

Type Source Name
disease MESH maternal deaths
disease MESH COVID-19 pandemic
disease MESH Live Births
disease MESH death
disease MESH postpartum hemorrhage
disease MESH infection
disease IDO quality
disease MESH morbidity
drug DRUGBANK Coenzyme M
drug DRUGBANK Hydroxyethyl Starch
disease MESH educational attainment
disease MESH influenza
drug DRUGBANK Gold
disease MESH complications
drug DRUGBANK Potassium
disease IDO process
disease MESH causes
drug DRUGBANK Ribostamycin
disease IDO country
disease MESH heart failure

Original Article

(Visited 2 times, 1 visits today)